chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: MNQ
Symptoms: Underdose
Clinical narrative: Patient did not receive both vials of Menveo; Patient did not receive both vials of Menveo; This non-serious case was reported by a other health professional via sales rep and described the occurrence of inappropriate preparation of medication in a adult female patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On an unknown date, the patient received the 1st dose of Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: Patient did not receive both vials of Menveo) and inappropriate dose of vaccine administered (Verbatim: Patient did not receive both vials of Menveo). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 04-FEB-2025 The Healthcare Professional reported that patient received the 1st dose of Menveo vaccine but did not received both vials. The patient received only adjuvant of Menveo, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Herpes virus infection
Clinical narrative: I had a herpies outbreak two days later and still getting them now; This non-serious case was reported by a consumer and described the occurrence of herpes virus infection in a 61-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 09-OCT-2024, the patient received Shingrix. In OCT-2024, 2 days after receiving Shingrix, the patient experienced herpes virus infection (Verbatim: I had a herpies outbreak two days later and still getting them now). The outcome of the herpes virus infection was not resolved.   The reporter considered the herpes virus infection to be related to Shingrix.     The company considered the herpes virus infection to be related to Shingrix.   Additional Information: GSK Receipt Date: 06-FEB-2025 The patient had a herpes outbreak two days later and still got them now all the time.  This was caused by GlaxoSmithKline vaccine
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Herpes simplex
Clinical narrative: I had a herpies outbreak two days later and still getting them now; This non-serious case was reported by a consumer and described the occurrence of herpes virus infection in a 61-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 09-OCT-2024, the patient received Shingrix. In OCT-2024, 2 days after receiving Shingrix, the patient experienced herpes virus infection (Verbatim: I had a herpies outbreak two days later and still getting them now). The outcome of the herpes virus infection was not resolved.   The reporter considered the herpes virus infection to be related to Shingrix.     The company considered the herpes virus infection to be related to Shingrix.   Additional Information: GSK Receipt Date: 06-FEB-2025 The patient had a herpes outbreak two days later and still got them now all the time.  This was caused by GlaxoSmithKline vaccine
Age: 0.17
Sex: F
Vaccine: HEP
Symptoms: Wrong product administered
Clinical narrative: 2-month-old patient in ICU inadvertently given HepB (Engerix-B) alone instead of Pediarix; This non-serious case was reported by a pharmacist via sales rep and described the occurrence of wrong vaccine administered in a 2-month-old female patient who received HBV (Engerix B) for prophylaxis.   Co-suspect products included DTPa-HBV-IPV (Pediarix) for prophylaxis.   On 07-FEB-2025, the patient received Engerix B. On an unknown date, the patient received Pediarix. On 07-FEB-2025, an unknown time after receiving Engerix B and not applicable after receiving Pediarix, the patient experienced wrong vaccine administered (Verbatim: 2-month-old patient in ICU inadvertently given HepB (Engerix-B) alone instead of Pediarix). The outcome of the wrong vaccine administered was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 07-FEB-2025 The pharmacist reported that the patient in intensive care unit (ICU) inadvertently given Hepatitis B (Engerix-B) alone instead of Pediarix, which led wrong vaccine administered. The reporter did not report any adverse effects and the infant was being monitored,
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Patient developed shingles after first dose administered; This non-serious case was reported by a nurse via sales rep and described the occurrence of shingles in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   In MAY-2024, the patient received the 1st dose of Shingrix. In AUG-2024, between 2 and 4 months after receiving Shingrix, the patient experienced shingles (Verbatim: Patient developed shingles after first dose administered). The outcome of the shingles was resolved.   It was unknown if the reporter considered the shingles to be related to Shingrix.     It was unknown if the company considered the shingles to be related to Shingrix.   Additional Information: GSK Receipt Date: 10-FEB-2025 The nurse reported that patient developed shingles after administration of first dose of Shingrix vaccine The patient developed shingles in August 2024 before receiving second dose.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Pain, Vaccination failure
Clinical narrative: Supected vaccination failure; got shingles after I got the vaccination/ it was on neck and face; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 month after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Supected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: got shingles after I got the vaccination/ it was on neck and face). The outcome of the vaccination failure was not reported and the outcome of the shingles was resolved (duration 2 months).   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     The company considered the vaccination failure to be unrelated to Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine.   Additional Information: GSK receipt date: 22-JAN-2025 This case was reported by a patient via interactive digital media. Patient stated that he/she got shingles after vaccination about a month later. Patient reported that it was on neck and face. It lasted 2 long painful months. Patient ended up in the emergency room and the doctor was so excited to see it. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of disease) is considered unrelated to GSK Shingles vaccine.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Suspected vaccination failure; I had the vaccine, still got shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: I had the vaccine, still got shingles). The outcome of the vaccination failure and shingles were not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     The company considered the vaccination failure to be unrelated to Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 04-FEB-2025 This case was reported by a patient via interactive digital media. The patient received Shingles vaccine and still got shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of disease) is considered unrelated to GSK Shingles vaccine.
Sex: U
Vaccine: RVX
Symptoms: Malaise
Clinical narrative: still got sick; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis.   On an unknown date, the patient received RSV vaccine. On an unknown date, an unknown time after receiving RSV vaccine, the patient experienced sickness (Verbatim: still got sick). The outcome of the sickness was resolved.   It was unknown if the reporter considered the sickness to be related to RSV vaccine.     It was unknown if the company considered the sickness to be related to RSV vaccine.   Additional Information: GSK Receipt Date: 10-FEB-2025 This case was reported by a patient via interactive digital media. The reporter reported that he/she got his/her shot and still got sick.  Maybe not as bad and did not lasted as long.
Sex: U
Vaccine: VARZOS
Symptoms: Pain
Clinical narrative: had my second dose of Shingrix yesterday and am feeling a bit achy and sore; This non-serious case was reported by a consumer and described the occurrence of pain in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date).   On 30-JAN-2025, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced pain (Verbatim: had my second dose of Shingrix yesterday and am feeling a bit achy and sore). The outcome of the pain was resolved.   It was unknown if the reporter considered the pain to be related to Shingrix.     It was unknown if the company considered the pain to be related to Shingrix.   Additional Information: GSK receipt date: 03-FEB-2025 The patient reported that he/she had a second dose of Shingrix yesterday (day before posting) and experienced feeling a bit achy and sore but it was absolutely worth it to greatly reduce his/her risk of shingles.
Sex: F
Vaccine: HEPAB
Symptoms: Incomplete course of vaccination
Clinical narrative: received Twinrix dose 1 on 04-JUL-2024, dose 2 on 07-AUG-2024 but she has yet to receive dose 3; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received HAB (Twinrix) for prophylaxis.   Previously administered products included Twinrix (Received 1st dose of Twinrix vaccine on 04-JUL-2024.) and Twinrix (Received 2nd dose of Twinrix vaccine on 07-AUG-2024.).   On an unknown date, the patient did not receive the 3rd dose of Twinrix. On an unknown date, an unknown time after receiving Twinrix, the patient experienced incomplete course of vaccination (Verbatim: received Twinrix dose 1 on 04-JUL-2024, dose 2 on 07-AUG-2024 but she has yet to receive dose 3). The outcome of the incomplete course of vaccination was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 13-JAN-2025 The reporter is the husband of a patient.    The patient received Twinrix dose 1 on 04 July 2024 and dose 2 on 07 August 2024 but she had yet to receive dose 3 which led to incomplete course of vaccination. The reporter had mentioned at the end of the conversation that a pharmacy technician was a certified immunizer though he was not practicing currently. Did not consent to follow-up.
Age: 19.0
Sex: F
Vaccine: TDAP
Symptoms: Exposure during pregnancy, Extra dose administered
Clinical narrative: received another dose of Boostrix by accident to patient 32 weeks pregnant; administered a 1st dose of Boostrix to a pregnant; Two doses of Boostrix during pregnancy.; This non-serious prospective pregnancy case was reported by a other health professional via call center representative and described the occurrence of vaccine exposure during pregnancy in a 19-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number XN575, expiry date 22-MAR-2027) for prophylaxis.   Co-suspect products included DTPa (Reduced antigen) (Boostrix) (batch number MC7HK, expiry date 25-JAN-2027) for prophylaxis.   On 15-JAN-2025, the patient received the 2nd dose of Boostrix. On 02-JAN-2025, the patient received the 1st dose of Boostrix. On 15-JAN-2025, an unknown time after receiving Boostrix and not applicable after receiving Boostrix, the patient experienced extra dose administered (Verbatim: Two doses of Boostrix during pregnancy.). On an unknown date, the patient experienced vaccine exposure during pregnancy (Verbatim: received another dose of Boostrix by accident to patient 32 weeks pregnant) and vaccine exposure during pregnancy (Verbatim: administered a 1st dose of Boostrix to a pregnant). The outcome of the vaccine exposure during pregnancy, vaccine exposure during pregnancy and extra dose administered were unknown.   Pregnancy exposure: Pregnancy Exposure (Boostrix): To mother in third trimester Pregnancy Exposure (Boostrix): To mother in third trimester Pregnancy Outcome: Pregnancy was ongoing   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 15-JAN-2025 The reporter informed that they administered a dose of Boostrix to a pregnant patient and same patient received another dose of Boostrix by accident, which led vaccine exposure during pregnancy and extra dose administered. Reporter mentioned patient was 32 weeks pregnant when she received the 2nd dose of Boostrix.  The reporter consented to follow up
Sex: U
Vaccine: HEPAB
Symptoms: Incomplete course of vaccination
Clinical narrative: did not come back to receive the third dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a patient who received HAB (Twinrix) for prophylaxis.   Previously administered products included Twinrix (received 1st dose on an unknown date) and Twinrix (2nd dose in September 2024).   On an unknown date, the patient did not receive the 3rd dose of Twinrix. On an unknown date, an unknown time after receiving Twinrix, the patient experienced incomplete course of vaccination (Verbatim: did not come back to receive the third dose). The outcome of the incomplete course of vaccination was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 15-JAN-2025 The patient received first dose and second dose of Twinrix on time according to accelerated schedule (0, 7 days, 21 to 30 days, and 12 months), but they did not come back to receive the third dose that supposed to be given in October 2024, and it was January 2025 now.  Till the time of reporting the patient had not received the third dose of Twinrix, which led to incomplete course of vaccination. The reporter did not had any patient demographics, and did not know why it was indicated for this patient to have an accelerated schedule.  The reporter did not consent to follow-up.
Sex: F
Vaccine: VARZOS
Symptoms: Incomplete course of vaccination
Clinical narrative: but has not received the second dose yet; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose over one year ago).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: but has not received the second dose yet). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 30-JAN-2025 The pharmacist reported that a patient received the first dose of Shingrix over one year ago but has not received the second dose yet. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination
Age: 53.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Product administered at inappropriate site, Skin irritation
Clinical narrative: irritation; redness in her left arm; vaccine was given in a site close to the elbow instead of the left deltoid; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of skin irritation in a 53-year-old female patient who received Herpes zoster (Shingrix) (batch number X5T42) for prophylaxis.   On 31-JAN-2025, the patient received the 1st dose of Shingrix (intramuscular, left arm). On 31-JAN-2025, less than a day after receiving Shingrix, the patient experienced skin irritation (Verbatim: irritation), erythema of extremities (Verbatim: redness in her left arm) and vaccine administered at inappropriate site (Verbatim: vaccine was given in a site close to the elbow instead of the left deltoid). The outcome of the skin irritation and erythema of extremities were not resolved and the outcome of the vaccine administered at inappropriate site was unknown.   It was unknown if the reporter considered the skin irritation and erythema of extremities to be related to Shingrix.     It was unknown if the company considered the skin irritation and erythema of extremities to be related to Shingrix.   Additional Information: GSK Receipt Date: 15-JAN-2025 The pharmacist is the reporter who stated a patient received her first Shingrix vaccine 31-JAN-2025. Patient called with irritation, redness in her left arm. HCP noticed the vaccine was given in a site close to the elbow instead of the left deltoid, which led to vaccine administered at inappropriate site. This case is linked with case US2020238768 by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020238768:same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Inappropriate schedule of product administration
Clinical narrative: past the 6-month timeframe for the 2nd Shingrix dose.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (Received 1st dose on an unknown date).   On an unknown date, the patient did not received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: past the 6-month timeframe for the 2nd Shingrix dose.). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 04-FEB-2025 The pharmacist enquired, If it has been more than 6 months does the series need to be restarted for Shingrix vaccine. The pharmacist confirmed with the Health Care Professional that the patient was past the 6-month timeframe for the 2nd dose of Shingrix.  The Vaccine Administration Facility is the same as Primary Reporter. As the patient did not receive the second dose of vaccine within the recommended timeframe, which led to incomplete course of vaccination
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: Asthma, Liver disorder, Pneumonia, Respiratory syncytial virus infection
Clinical narrative: developed pneumonia; Asthma; liver problems; developed RSV; This spontaneous case was reported by a patient and describes the occurrence of PNEUMONIA (developed pneumonia) in a 73-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7162B) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 22-Sep-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular use) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to 1 dosage form, dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to 1 dosage form and dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PNEUMONIA (developed pneumonia) (seriousness criterion medically significant), ASTHMA (Asthma), LIVER DISORDER (liver problems) and RESPIRATORY SYNCYTIAL VIRUS INFECTION (developed RSV). At the time of the report, PNEUMONIA (developed pneumonia) had not resolved and ASTHMA (Asthma), LIVER DISORDER (liver problems) and RESPIRATORY SYNCYTIAL VIRUS INFECTION (developed RSV) outcome was unknown.            No concomitant medication was reported. It was unknown if the patient experienced any additional symptoms/events.  Reporter causality was not reported. No treatment medication was reported.   This case was linked to MOD-2025-782184 (Patient Link).   Reporter did not allow further contact; Reporter's Comments: The benefit-risk relationship of product is not affected by this report.
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Dizziness, Fatigue
Clinical narrative: loss of appetite; dizziness; fatigue; This spontaneous case was reported by a non-health professional and describes the occurrence of DECREASED APPETITE (loss of appetite), DIZZINESS (dizziness) and FATIGUE (fatigue) in a female patient of an unknown age who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (loss of appetite), DIZZINESS (dizziness) and FATIGUE (fatigue). At the time of the report, DECREASED APPETITE (loss of appetite), DIZZINESS (dizziness) and FATIGUE (fatigue) was resolving.        The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) was unknown.       No concomitant medication was reported.  Reporter causality was not reported. It was unknown if the patient experienced any additional symptoms or events.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: COVID after Vaccine; COVID after Vaccine; This is a spontaneous report received from a Consumer or other non HCP, Program ID.  A 64-year-old female patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (dose 1, manufacturer unknown), for COVID-19 immunization; Covid-19 vaccine (dose 2, manufacturer unknown), for COVID-19 immunization; Covid-19 vaccine (dose 3 (booster), manufacturer unknown), for COVID-19 immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID after Vaccine". Therapeutic measures were taken as a result of drug ineffective, covid-19 and included treatment with PAXLOVID. The patient was coughing. The patient got the original two and then got a booster and a booster. The patient haven't gotten one this year, but patient got some of the vaccinations. Patient was not unvaccinated.
Sex: M
Vaccine: COVID19
Symptoms: Alopecia, Condition aggravated
Clinical narrative: after receiving the COVID vaccine he noticed his hair loss became much more rapid; after receiving the COVID vaccine he noticed his hair loss became much more rapid; This is a spontaneous report received from a Consumer or other non HCP, Program ID.  A 35-year-old male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ALOPECIA (non-serious), CONDITION AGGRAVATED (non-serious), outcome "unknown" and all described as "after receiving the COVID vaccine he noticed his hair loss became much more rapid".  Additional information: Patient was noticing hair loss due to alopecia, after receiving the COVID vaccine he noticed his hair loss became much more rapid.  No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: allergic reaction after it was administer; This is a spontaneous report received from a Consumer or other non HCP, Program ID.  A female patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HYPERSENSITIVITY (non-serious), outcome "unknown", described as "allergic reaction after it was administer". Additional information: she was trying to report an allergic reaction after it was administer. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
Age: 1.08
Sex: F
Vaccine: DTPPVHBHPB
Symptoms: Febrile convulsion, Generalised tonic-clonic seizure, Lethargy, Vomiting projectile
Clinical narrative: Febrile seizure occurred approximately 12 hours after vaccine administration, described by mother as generalized tonic-clonic followed by projectile vomiting and lethargy. Temp in ED noted to be 102.7F rectal.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Malaise, Nausea, Pain in extremity
Clinical narrative: Patient phoned clinic on 2/7/25 informing office of not feeling well, arms still feels achy, has some chills, taking tylenol PRN. Phoned office 2/10/25 complaining of nervous stomach issues, gurgling and jumpiness, nausea.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Heart rate increased
Clinical narrative: Rapid heart, high resting heart rate, difficulty breathing
Age: 54.0
Sex: F
Vaccine: FLU3, PNC20
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Pruritus
Clinical narrative: Patient received Prevnar-20 on 2/5/25. She came to the pharmacy on 2/10/25 to show me her arm which was red and swollen. She stated she had slight pain on the day she received the vaccine and 3 days later her right arm became itchy and had a raised area. On 2/9/25 redness appeared. I did inform patient that a swollen, red are may be a side effect of the Prevnar-20 vaccine, but if she was concerned she could visit her family physician or urgent care. She told me she was going to ice today and see if it improves and will call us back.  I called patient back on 2/12/25 and she stated she may go to the doctor tomorrow - not completely resolved.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site bruising, Injection site discharge, Injection site reaction, Injection site swelling, Injection site warmth
Clinical narrative: My left arm got really swollen warm to touch and bruised with a bumpy itchy rash with secretions on top of injection site which led me to visit my PCP. In which he recommend me not to get any more covid vaccinations due to life threatening reaction.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash pruritic
Clinical narrative: My left arm got really swollen warm to touch and bruised with a bumpy itchy rash with secretions on top of injection site which led me to visit my PCP. In which he recommend me not to get any more covid vaccinations due to life threatening reaction.
Age: 42.0
Sex: F
Vaccine: MMR
Symptoms: Infection, Injected limb mobility decreased, Injection site bruising, Injection site mass, Injection site pain
Clinical narrative: Pain, knot of right arm in area of the vaccine taken, bruising, difficult to do range of motion because of pain. I have been icing and massages.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Patient states that vaccine, hurt when administered and is still having intermittent pain in arm, mostly when he lays on the arm
Age: 56.0
Sex: F
Vaccine: PNC21
Symptoms: Axillary pain, Breast pain, Oedema peripheral
Clinical narrative: Patient states that starting the day of vaccination she has been experiencing swelling and pain in her axilla and breast.
Age: 0.17
Sex: M
Vaccine: DTAPHEPBIP, PNC13, RV5
Symptoms: Apnoea, Hypotonia, Respiratory arrest
Clinical narrative: SIDS episode four days later. I found him limp, lifeless, and not breathing. After some stimulation he began breathing normal again. Hospital charted it as an apnea episode
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Abdominal pain upper, Disorientation, Nausea, Vomiting
Clinical narrative: Vaccine given at 2/11/2025 at 2:49 pm. Patient's mother called on-call Doctor around 2/11/2025 at around 6pm for concerning symptoms including nausea, stomach cramps, vomiting, and disorientation.  On call Doctor advised emergency care. On 2/12/2025 at 8:15am, RN called for follow up, mother stated that the disorientation and vomiting had subsided and was only having some nausea and stomach cramping. Mother stated that they decided to not seek care, against the advice of staff.
Age: 0.33
Sex: F
Vaccine: DTPPVHBHPB
Symptoms: Chest X-ray normal, Cyanosis, Electrocardiogram, Laboratory test, Musculoskeletal stiffness
Clinical narrative: 10:30 p, pt stopped breathing for 4 min, stiff and blue, called 911 tilted chin back and she started to respond to breathing. 911 can and checked on her offered ED. pt did not go to the ED, episode lasted 4 mins.
Age: 0.33
Sex: F
Vaccine: DTPPVHBHPB
Symptoms: Respiratory arrest
Clinical narrative: 10:30 p, pt stopped breathing for 4 min, stiff and blue, called 911 tilted chin back and she started to respond to breathing. 911 can and checked on her offered ED. pt did not go to the ED, episode lasted 4 mins.
Age: 75.0
Sex: F
Vaccine: RSV
Symptoms: Extra dose administered
Clinical narrative: duplicate vaccine... also received in Octo bet 2024
Age: 17.0
Sex: M
Vaccine: MENB
Symptoms: Chills, Eye pain, Influenza A virus test negative, Influenza B virus test negative, Injection site pain
Clinical narrative: Fever, chills, pain behind eyes, light sensitivity, restless sleep due to pain at the vaccine site.
Age: 17.0
Sex: M
Vaccine: MENB
Symptoms: Photophobia, Poor quality sleep, Pyrexia, Respiratory pathogen panel, Streptococcus test negative
Clinical narrative: Fever, chills, pain behind eyes, light sensitivity, restless sleep due to pain at the vaccine site.
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling, Pyrexia
Clinical narrative: swelling and redness on the application site, fever
Age: 77.0
Sex: F
Vaccine: FLU3
Symptoms: Extra dose administered, No adverse event
Clinical narrative: No Adverse events occurred. Patient received two doses of Fluzone HD.  First Immunization given 10-9-25 and 2nd immunization given 12-18-25.  Patient had no side effects or adverse events.
Age: 82.0
Sex: M
Vaccine: FLU3
Symptoms: Extra dose administered, No adverse event
Clinical narrative: No Adverse events occurred. Patient received two doses of Fluzone HD.  First Immunization given 10-9-25 and 2nd immunization given 12-18-25.  Patient had no side effects or adverse events.
Age: 27.0
Sex: F
Vaccine: ANTH
Symptoms: Injection site cellulitis, Pyrexia
Clinical narrative: Patient presented on day 7 after vaccine, having first developed symptoms on day 5 after vaccine.  She was diagnosed with nonpurulent cellulitis at the vaccine site, with induration of approximately 8.5cm x 10cm.  She did not have systemic symptoms, including fever.  She was prescribed Keflex.
Age: 16.0
Sex: M
Vaccine: HEP, IPV, MMR
Symptoms: Balance disorder, Dizziness, Pallor, Syncope
Clinical narrative: Vaccine appointment, review eligibility, contraindications and VIS. Vaccine preparation, administration and documentation. Scanned files into nightingale notes. Administered Hep B, without apparent reactions. Administered MMR and patient appeared pale and unsteady. He was able to stand and change sides without apparent difficulties. Administered Polio vaccine and placed band aid, patient appeared to faint, eyes remained open but slid off chair, forward onto knees. Guardian and writer were able to hold him steady with no apparent injuries. He was able to state name, birthday and reported feeling dizzy/lightheaded. Remained sitting on the floor, asked for water. Writer called (co worker) for additional support. Patient was able to stand and sit in chair. Vitals taken 98% O2, 74 P, 16RR and 118/68 BP. Remained with patient for 30 min, appeared comfortable and left for home. To call as needed.
Age: 10.0
Sex: F
Vaccine: HEPA
Symptoms: Incorrect dose administered
Clinical narrative: Vaccinator administered an Adult dose  Hepatitis A vaccine (Havarix)1.0ml to a 10 year old child.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Arterial injury, Cardiac arrest, Cardiac stress test abnormal, Catheterisation cardiac abnormal, Coronary arterial stent insertion
Clinical narrative: Diagnosed with myocarditis following ER visit in January 2024 with no history of heart problems. Primary complaint for months leading up to that point was frequent tingling and weakness in both legs. Did not resolve after ER visit, failed stress test. Cardiac catheterization was performed 2/2024 with stent placement due to damaged diagonal vein in heart. At some point in medical records diagnosis was changed to pericarditis. Never diagnosed with hypertension or high blood pressure. Died 12/09/2024 of cardiac arrest. He had received his 2nd Pfizer injection on 05/26/2021 at facility, product number EW0187.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Muscular weakness, Myocarditis, Paraesthesia, Pericarditis
Clinical narrative: Diagnosed with myocarditis following ER visit in January 2024 with no history of heart problems. Primary complaint for months leading up to that point was frequent tingling and weakness in both legs. Did not resolve after ER visit, failed stress test. Cardiac catheterization was performed 2/2024 with stent placement due to damaged diagonal vein in heart. At some point in medical records diagnosis was changed to pericarditis. Never diagnosed with hypertension or high blood pressure. Died 12/09/2024 of cardiac arrest. He had received his 2nd Pfizer injection on 05/26/2021 at facility, product number EW0187.
Age: 71.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Post herpetic neuralgia, Rash
Clinical narrative: He got shingles. He came in because he thought the rash was bedbugs but he had shingles in 2 contiguous dermatomes - T9ish on the right. He then came back to see me again today, 2/12/2025, because he now has postherpetic neuralgia.  I understand that you can't get shingles from the vaccine because there's no live virus in the vaccine,,but he has a history of chickenpox. Could the vaccine or the resulting immune response have caused his VZV to reactivate and cause the disease?
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Palpitations, Sleep disorder
Clinical narrative: Palpitations lasting 4 hours and HR up to 152. Sat decreased to 89% on room air. now at 94 with HR 102.Unable to sleep for next 4 ours. Myalgia severe ongoing after Spikevax12+ given yesterday afternoon.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Diplopia, Magnetic resonance imaging head normal, Scan with contrast normal, VIth nerve paralysis
Clinical narrative: Patient developed acute, painless vertical diplopia less than 24 hours after receiving her COVID shot. MRI brain with and without contrast was unremarkable. Subsequent ophthalmologic evaluation showed an acute, isolated left-sided cranial nerve 6 palsy.
Age: 14.0
Sex: F
Vaccine: MMR, YF
Symptoms: Extra dose administered
Clinical narrative: Patient in office for catch up vaccination. She received all catch up needed including  MMR and Varicella. Patient didn't need an extra dose of MMR and Varicella as she has already completed vaccine series.
Age: 17.0
Sex: M
Vaccine: FLU3
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient was given a 3rd dose of MCV4O instead of 2nd dose of meningococcal B (MenB). No adverse reaction, no treatment needed. Called patient to have appointment scheduled for 2nd MenB administered.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Pain, Vomiting
Clinical narrative: she is feeling horrible today, she is complaining of body aches, vomiting and chills
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy bone marrow, Blood test, CALR gene mutation, Essential thrombocythaemia, Gene mutation identification test positive
Clinical narrative: I received the Pfizer COVID vaccine in April and May of 2021. Prior to that vaccine series, my platelet counts were always in normal lab range. After the vaccine series, my platelet count rose continually and were outside the normal lab ranges. I went to a hematologist in March 2023 and after blood work, genetic testing and a bone marrow biopsy, I was diagnosed with essential thrombocytosis (ET) with a CALR mutation  on exon 9 in September 2023. My correlation is the COVID vaccine series disrupted my genetics and caused the ET. I had no history of high platelets prior to the COVID vaccine series.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Platelet count increased
Clinical narrative: I received the Pfizer COVID vaccine in April and May of 2021. Prior to that vaccine series, my platelet counts were always in normal lab range. After the vaccine series, my platelet count rose continually and were outside the normal lab ranges. I went to a hematologist in March 2023 and after blood work, genetic testing and a bone marrow biopsy, I was diagnosed with essential thrombocytosis (ET) with a CALR mutation  on exon 9 in September 2023. My correlation is the COVID vaccine series disrupted my genetics and caused the ET. I had no history of high platelets prior to the COVID vaccine series.
Age: 76.0
Sex: F
Vaccine: PNC21
Symptoms: Balance disorder, Malaise, Mobility decreased, Pain, Tremor
Clinical narrative: Patient said she woke up in the middle of the night after getting the vaccine and "something was wrong". She states she didn't feel right and couldn't keep her balance. She also reported uncontrollable shaking (like she was feverish, without a fever) and total body aches. She states she is now "unable to get around."
Age: 15.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Syncope
Clinical narrative: Patient fainted in pharmacy waiting room after receiving covid and flu vaccines on 2/11/25 around 7pm. Her father was also present. Her face appeared pale but was otherwise ok and responsive to questions. She was instructed to sit down and given water and granola snack bar. She began to recover quickly and was monitored for any additional side effects or symptoms. Patient indicated she had not eaten since school and had not eaten dinner. She left pharmacy with father and was feeling well. Patient and father were instructed to call us if symptoms returned or worsened.
Age: 34.0
Sex: F
Vaccine: HPV9
Symptoms: Abdominal pain, Alpha-1 anti-trypsin, Amnesia, Antibody test, Anxiety
Clinical narrative: Between 09/1/23 - 11/15/23 - Abdominal & Urinary pain, feeling of a UTI or Hernia, No confirmation of UTI, slight Confirmation of Hernia. Stroke like symptoms, blurred vison, memory loss, tingling & numbness on right ride of the body, extreme fatigue , anxiety, loss of balance,
Age: 34.0
Sex: F
Vaccine: HPV9
Symptoms: Balance disorder, Blood glucose normal, Blood iron, Blood thyroid stimulating hormone, Electrophoresis protein normal
Clinical narrative: Between 09/1/23 - 11/15/23 - Abdominal & Urinary pain, feeling of a UTI or Hernia, No confirmation of UTI, slight Confirmation of Hernia. Stroke like symptoms, blurred vison, memory loss, tingling & numbness on right ride of the body, extreme fatigue , anxiety, loss of balance,
Age: 34.0
Sex: F
Vaccine: HPV9
Symptoms: Fatigue, Glycosylated haemoglobin, HIV test negative, Hernia, Hypoaesthesia
Clinical narrative: Between 09/1/23 - 11/15/23 - Abdominal & Urinary pain, feeling of a UTI or Hernia, No confirmation of UTI, slight Confirmation of Hernia. Stroke like symptoms, blurred vison, memory loss, tingling & numbness on right ride of the body, extreme fatigue , anxiety, loss of balance,
Age: 34.0
Sex: F
Vaccine: HPV9
Symptoms: Light chain analysis, Neurological symptom, Paraesthesia, Serum ferritin decreased, Sexually transmitted disease test
Clinical narrative: Between 09/1/23 - 11/15/23 - Abdominal & Urinary pain, feeling of a UTI or Hernia, No confirmation of UTI, slight Confirmation of Hernia. Stroke like symptoms, blurred vison, memory loss, tingling & numbness on right ride of the body, extreme fatigue , anxiety, loss of balance,
Age: 34.0
Sex: F
Vaccine: HPV9
Symptoms: Urinary tract pain, Urine analysis, Vision blurred, Vitamin D decreased, Vitamin test
Clinical narrative: Between 09/1/23 - 11/15/23 - Abdominal & Urinary pain, feeling of a UTI or Hernia, No confirmation of UTI, slight Confirmation of Hernia. Stroke like symptoms, blurred vison, memory loss, tingling & numbness on right ride of the body, extreme fatigue , anxiety, loss of balance,
Age: 60.0
Sex: M
Vaccine: VARCEL
Symptoms: Adverse reaction, Wrong product administered
Clinical narrative: Patient received varivax vaccine instead of varicella-zoster lab work. Provider made aware and discussed with the patient of the error. Patient voiced is fine. No adverse reactions noted.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test normal, Computerised tomogram head normal, Confusional state, Erythema, Gait inability
Clinical narrative: husband said he helped pt out of the bed but she got her foot caught under a rug so he had to help her into a rolling chair to move her around. She had confusion, her right was swollen around the injection site and she was running fever. He assisted her to the kitchen table and then to the living room chair in the rolling chair because she was unable to walk on her own. He contacted a nurse friend of theirs and she was concerned that she may have had a stroke and recommended she be taken to the ER. He contacted an ambulance to take her to ER Hospital. They did multiple test that were all normal. She was running fever and her right arm was red so she was admitted for observation for 48 hours. She was discharged after PT and OT approved her to go home and told to contact PCP for follow up.  She is scheduled to be seen on 2/17/25.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Laboratory test normal, Pyrexia, SARS-CoV-2 test negative, Walking aid user
Clinical narrative: husband said he helped pt out of the bed but she got her foot caught under a rug so he had to help her into a rolling chair to move her around. She had confusion, her right was swollen around the injection site and she was running fever. He assisted her to the kitchen table and then to the living room chair in the rolling chair because she was unable to walk on her own. He contacted a nurse friend of theirs and she was concerned that she may have had a stroke and recommended she be taken to the ER. He contacted an ambulance to take her to ER Hospital. They did multiple test that were all normal. She was running fever and her right arm was red so she was admitted for observation for 48 hours. She was discharged after PT and OT approved her to go home and told to contact PCP for follow up.  She is scheduled to be seen on 2/17/25.
Age: 15.0
Sex: M
Vaccine: HPV9
Symptoms: Arthralgia, Mobility decreased
Clinical narrative: Left shoulder pain with decreased range of motion.
Age: 55.0
Sex: F
Vaccine: COVID19, VARZOS
Symptoms: Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Received vaccine at about 9:30 A.M. on February 8. Patient says by that evening, her arm began swelling, became hot to the touch and itchy. Swelling has spread away from vaccine site down to her elbow and around to the inside of her upper arm over the last 4 days. Benadryl helped to relieve some of the itching, but the swelling and redness remains.
Age: 1.0
Sex: M
Vaccine: DTAPIPVHIB, HEPA, MMR, PNC20
Symptoms: Diarrhoea, Irritability, Pyrexia
Clinical narrative: Extreme irritability, loose stool, fever
Age: 16.0
Sex: F
Vaccine: HPV9, MENB, MNQ
Symptoms: Fall, Head injury
Clinical narrative: Patient fell after standing up to get her sweatshirt. Pt fell to the ground she did hit her head, not sure if that was impacted on the chair or on the floor. Patient was taken to ER for treatment
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Expired product administered
Clinical narrative: Vaccine listed as Kinrix was past expiration date Vaccine expired on 1/25/25 and was given on 2/5/25.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Age-inappropriate vaccination. The patient received Moderna vaccine scheduled for patient 6 months to 11 years
Age: 16.0
Sex: M
Vaccine: MENB
Symptoms: Fatigue, Headache, Pain in extremity, Peripheral swelling, Pyrexia
Clinical narrative: Fatigue, Arm Swelling/Soreness, Headache, Fever
Age: 9.0
Sex: F
Vaccine: HEPA
Symptoms: Extra dose administered
Clinical narrative: The patient had a physical on 2/5/25 at the clinic. During the physical, the patient had another dose of Hepatitis A vaccine.  She was accompanied by her father who was given the VIS for the Hepatitis A vaccine and agreed to go forward with the vaccine.  On 2/11/25, staff from the DPH called the clinic to inform us that the patient had previously received a dose of Hepatitis A at the DPH on 1/28/25.